http://orcid.org/0000-0001-6825-6131
References
- Cabezón-Gutiérrez L, Khosravi-Shahi P, Custodio-Cabello S, Muñiz-González F, Cano-Aguirre Mdel P, Alonso-Viteri S. Opioids for management of episodic breathlessness or dyspnea in patients with advanced disease. Support Care Cancer 2016;24:4045–55. doi: 10.1007/s00520-016-3316-x
- Ben-Aharon I, Gafter-Gvili A, Leibovici L, Stemmer SM. Interventions for alleviating cancer-related dyspnea: a systematic review and meta-analysis. Acta Oncol 2012;51:996–1008. doi: 10.3109/0284186X.2012.709638
- Yamaguchi T, Goya S, Kohara H, Watanabe H, Mori M, Matsuda Y, et al. Treatment recommendations for respiratory symptoms in cancer patients: clinical guidelines from the Japanese society for palliative medicine. J Palliat Med 2016;19:925–35. doi: 10.1089/jpm.2016.0145
- Guirimand F, Sahut d’izarn M, Laporte L, Francillard M, Richard JF, Aegerter P. Sequential occurrence of dyspnea at the end of life in palliative care, according to the underlying cancer. Cancer Med 2015;4:532–9. doi: 10.1002/cam4.419
- Japanese Society for Palliative Medicine Clinical guidelines for respiratory symptoms in cancer patients. Tokyo: Kanehara; 2016. p. 14–17.
- Japanese Society for Palliative Medicine Clinical guidelines for respiratory symptoms in cancer patients. Tokyo: Kanehara; 2016. p. 25–30.
- Ben-Aharon I, Gafter-Gvili A, Paul M, Leibovici L, Stemmer SM. Interventions for alleviating cancer-related dyspnea: a systematic review. J Clin Oncol 2008;26:2396–404. doi: 10.1200/JCO.2007.15.5796
- Thomas JR, von Gunten CF. Clinical management of dyspnoea. Lancet Oncol 2002;3:223–8. doi: 10.1016/S1470-2045(02)00713-1
- Vargas-Bermúdez A, Cardenal F, Porta-Sales J. Opioids for the management of dyspnea in cancer patients: evidence of the last 15 years--a systematic review. J Pain Palliat Care Pharmacother 2015;29:341–52. doi: 10.3109/15360288.2015.1082005
- Matsuo N, Morita T, Iwase S. Efficacy and undesirable effects of corticosteroid therapy experienced by palliative care specialists in Japan: a nationwide survey. J Palliat Med 2011;14:840–5. doi: 10.1089/jpm.2011.0002
- Simon ST, Köskeroglu P, Bausewein C. Pharmacological therapy of refractory dyspnoea: a systematic literature review. Schmerz 2012;26:515–22. doi: 10.1007/s00482-012-1228-3
- Viola R, Kiteley C, Lloyd NS, Mackay JA, Wilson J, Wong RK, Supportive Care Guidelines Group of the Cancer Care Ontario Program in Evidence-Based Care. The management of dyspnea in cancer patients: a systematic review. Support Care Cancer 2008;16:329–37. doi: 10.1007/s00520-007-0389-6
- Miyashita M, Matoba K, Sasahara T, Kizawa Y, Maruguchi M, Abe M, et al. Reliability and validity of the Japanese version of the support team assessment schedule (STAS-J). Palliat Support Care 2004;2:379–85. doi: 10.1017/S1478951504040507
- Ekström M, Allingham SF, Eagar K, Yates P, Johnson C, Currow DC. Breathlessness during the last week of life in palliative care: an Australian prospective, longitudinal study. J Pain Symptom Manage 2016;51:816–23. doi: 10.1016/j.jpainsymman.2015.12.311
- Ripamonti C. Management of dyspnea in advanced cancer patients. Support Care Cancer 1999;7:233–43. doi: 10.1007/s005200050255
- Lagman RL, Davis MP, LeGrand SB, Walsh D. Common symptoms in advanced cancer. Surg Clin North Am 2005;85:237–55. doi: 10.1016/j.suc.2004.11.004
- Yates P, Schofield P, Zhao I, Currow D. Supportive and palliative care for lung cancer patients. J Thorac Dis 2013;5:623–8.
- Zhao I, Yates P. Non-pharmacological interventions for breathlessness management in patients with lung cancer: a systematic review. Palliat Med 2008;22:693–701. doi: 10.1177/0269216308095024
- Corner J, Plant H, A’Hern R, Bailey C. Non-pharmacological intervention for breathlessness in lung cancer. Palliat Med 1996;10:299–305. doi: 10.1177/026921639601000405
- Hui D, Kilgore K, Frisbee-Hume S, Park M, Tsao A, Delgado Guay M, et al. Dexamethasone for dyspnea in cancer patients: a pilot double-blind, randomized, controlled trial. J Pain Symptom Manage 2016;52(1):8–16. doi: 10.1016/j.jpainsymman.2015.10.023